BioScience Managers – Page 7 – BioScience Managers

The Electrospinning Company – £4.5M Investment Led Confluent Medical

4th May 2021/in BioScience Managers

Link to Full Article Proceeds to be used to expand electrospinning capabilities & capacity, driving company growth Harwell, UK, May 4 2021 – The Electrospinning Company (Electrospinning), a leader in the development and manufacture of nanofibrous biomaterials for use in tissue regenerative devices, has completed a £4.5m ($6.3m) fundraising round, led US materials science company Confluent Medical Technologies Inc. (Confluent) […]

Destiny Pharma – Posting of Annual Report and Notice of AGM

4th May 2021/in BioScience Managers

Link to Full Article Posting of Annual Report and Accounts, and Notice of AGM Brighton, United Kingdom – 4 May 2021 – Destiny Pharma plc (AIM: DEST) a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, announces that the following documents are now available on the Company’s website at www.destinypharma.com […]

MIP Diagnostics continues 2021 success with ISO 9001 accreditation

1st May 2021/in BioScience Managers

Link to Full Article MIP Diagnostics, a UK manufacturer of molecularly imprinted polymers (MIPs) has achieved ISO 9001:2015 accreditation. MIP Diagnostics specialise in the development and manufacture of nanoscale molecularly imprinted polymers (nanoMIPs), which act as synthetic antibodies in diagnostic assays, sensors and other industry applications. After a strong start to 2021, MIP Diagnostics has […]

GEN INCODE ANNOUNCES MAJOR UK COLLABORATION WITH ROYAL BROMPTON AND HAREFIELD HOSPITALS

29th April 2021/in BioScience Managers

Link to Full Article GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces today a collaboration with Royal Brompton and Harefield hospitals (“RB&H”), recently merged with Guy’s and St Thomas’ NHS Foundation Trust (“GSTT”), to provide globally leading cardiovascular disease clinical genetic testing and reporting. GEN inCode specializes […]

MIP Diagnostic Synthetic antibody offers ultra-high sensitivity for next wave of COVID-19 sensors

22nd April 2021/in BioScience Managers

Link to Full Article MIP Diagnostics Ltd. has today announced the launch of its COVID-19 nanoMIP for diagnostic sensors, a synthetic alternative to antibodies that offers ultra-high sensitivity for the next wave of COVID-19 antigen detecting devices. nanoMIPs are nanoscale Molecularly Imprinted Polymers, commonly known as synthetic antibodies. They are manufactured around a template molecule […]

Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia

13th April 2021/in BioScience Managers

Link to Full Article Cambridge, United Kingdom and Singapore – 13 April 2021– Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces a strategic partnership with Camtech Diagnostics (“Camtech”), a technology company providing total solutions to the biodefence, food and clinical diagnostics sectors. The partnership […]

Congenica Appoints Jayesh Pankhania as Chief Financial Officer

6th April 2021/in BioScience Managers

Link to Full Article Cambridge, United Kingdom – 6 April 2021 – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the appointment of Jayesh Pankhania as Chief Financial Officer (CFO), effective immediately. Jayesh is a finance professional with nearly 30 years of global […]

TECHNOLOGY MIP TECHNOLOGY OUR PUBLICATIONS APPLICATIONS SENSORS IVD ASSAYS SIMPLIFIED WORKFLOW PRODUCTS COVID-19 IN DEVELOPMENT SERVICES CUSTOM MIP DEVELOPMENT EPITOPE DISCOVERY RESOURCES NEWS EVENTS ABOUT ABOUT US BOARD OF DIRECTORS MANAGEMENT TEAM April 15, 2021 Mike Dalrymple joins MIP Diagnostics as Head of Global Business Development

2nd April 2021/in BioScience Managers

Link to Full Article We are pleased to announce the appointment of Mike Dalrymple to the role of Head of Global Business Development at MIP Diagnostics on a consultancy basis. With over 30 years’ experience in diagnostics and therapeutics, Mike brings a wealth of knowledge and expertise to the business. Mike has a long track […]

Comgenica selected Institute of Immunology and Genetics in Kaiserslautern to accelerate its whole exome sequencing

31st March 2021/in BioScience Managers

Link to Full Article Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces a new contract with the Institute of Immunology and Genetics (‘IIG’ or the ‘Institute’) a leading molecular genetic laboratory in Kaiserslautern, Germany, equipped with state-of-the-art equipment and comprehensive human genetic and bioinformatic expertise. From analysis of established gene variants, […]

ARECOR RECEIVES £2.8 MILLION GRANT AWARD FROM INNOVATE UK

31st March 2021/in BioScience Managers

Link to Full Article Coveted award for Phase II clinical development of lead product, AT247, its next generation ultra-rapid acting Insulin Cambridge, UK., 31 st Mar 2021: Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that it has been awarded a £2.8 million grant from […]

Pages